Chang Ho Ahn
Director/Board Member at TheraTarget, Inc.
Chang Ho Ahn active positions
| Companies | Position | Start | End |
|---|---|---|---|
TheraTarget, Inc.
 TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Director/Board Member | - | - |
Career history of Chang Ho Ahn
Former positions of Chang Ho Ahn
| Companies | Position | Start | End |
|---|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Director/Board Member | 2015-06-21 | 2017-08-30 |
| Chairman | 2005-04-30 | 2015-06-21 | |
| Chief Tech/Sci/R&D Officer | 2011-03-07 | - | |
| Founder | 2001-03-18 | 2017-08-30 | |
| President | 2005-04-30 | 2013-02-04 | |
| Rexahn Corp. | Chief Executive Officer | 2001-02-28 | 2005-04-30 |
| Chairman | 2001-02-28 | 2005-04-30 | |
| The Society of Biomedical Research | President | 1999-12-31 | 2002-12-31 |
| Center for Drug Evaluation & Research | Corporate Officer/Principal | 1987-12-31 | 2000-12-31 |
Training of Chang Ho Ahn
| Creighton University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
| Seoul National University | Undergraduate Degree |
Statistics
International
| United States | 8 |
| South Korea | 2 |
Operational
| Director/Board Member | 2 |
| Chairman | 2 |
| President | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
| Rexahn Corp. | Finance |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Society of Biomedical Research | |
| Center for Drug Evaluation & Research | Government |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Stock Market
- Insiders
- Chang Ho Ahn
- Experience
